Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.
The Fred Hutch Immunotherapy Integrated Research Center (IIRC) seeks qualified candidates for its two-year Immunotherapy Physician Scientist Program. A successful applicant will be an MD or MD/PhD who is committed to pioneering major advances in medical practice through research. Applicants should be interested in an aspect of immuno-oncology relevant to the IIRC, as well as the development of therapies that modulate the immune system. Immunotherapy Physician Scientists will advance their academic careers by performing immuno-oncology research with access to state-of-the-art facilities and working with expert faculty mentors who are members in the Immunotherapy Integrated Research Center. Click here to view IIRC Faculty.
The IIRC will support the incumbent’s salary and lab expenses for two years of translational research training. However, the Physician Scientist is strongly encouraged to work with their mentor to apply for outside funding during their first year.
The Physician Scientist in this program will develop a research project under the guidance of an IIRC faculty mentor. Projects may be predominantly clinical, correlative or laboratory-based, but must be focused on the development and/or improvement of cancer immunotherapy. Candidates may identify projects that require guidance from more than one mentor, as long as one mentor is a Physician Scientist faculty member of the IIRC. Canidates may identify potential research projects and mentors as part of their application for the Physician Scientist Program.
The Physician Scientist will participate in outpatient (immunotherapy clinic) and/or inpatient (transplant/immunotherapy) service at Fred Hutch Cancer Center under the supervision of an attending physician. The candidate's participation in clinical activities may be either under observation status through the Medical Director’s Office or under their WA state medical license. Candidates need to meet minimum requirements for clinical activity, which will likely happen in Year 2. Typically, clinical activity is 2-4 months, based on the candidate’s license status and goals, and the need of the service.
Fred Hutch is a world leader in immunotherapy. An exceptionally strong history of research in immunotherapy (FH immunotherapy) and bone marrow transplantation (FH transplantation) informs and guides progress towards the development of the next generation of curative treatments. Available resources include outstanding staff, facilities and the infrastructure necessary to support translational immunotherapy research:
Your search for "" did not match any of our available careers. Please try another search term or combination of terms and filters.